The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2,6-dichlorophenyl)-3-(6-((3-fluoro-5-methylphenyl)amino)pyrimidin-4-yl)urea ID: ALA4537004
PubChem CID: 155548572
Max Phase: Preclinical
Molecular Formula: C18H14Cl2FN5O
Molecular Weight: 406.25
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(F)cc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1
Standard InChI: InChI=1S/C18H14Cl2FN5O/c1-10-5-11(21)7-12(6-10)24-15-8-16(23-9-22-15)25-18(27)26-17-13(19)3-2-4-14(17)20/h2-9H,1H3,(H3,22,23,24,25,26,27)
Standard InChI Key: YZDMQRNGIDAMFR-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
17.7044 -4.2386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7032 -5.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4154 -5.4754 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1292 -5.0618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1264 -4.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4136 -3.8298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4112 -3.0084 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8417 -5.4734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5529 -5.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6981 -2.5978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6990 -1.7773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9868 -1.3709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2794 -1.7816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2844 -2.6072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9931 -3.0140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5516 -4.2383 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.2654 -5.4712 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2628 -3.8286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9688 -4.2371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6795 -3.8280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6786 -3.0059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9612 -2.5944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2575 -3.0099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5433 -2.6014 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
21.9688 -5.0584 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.5753 -3.0245 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.9848 -0.5566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
4 8 1 0
8 9 1 0
7 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
9 16 1 0
9 17 2 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
23 24 1 0
19 25 1 0
14 26 1 0
12 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 406.25Molecular Weight (Monoisotopic): 405.0559AlogP: 5.62#Rotatable Bonds: 4Polar Surface Area: 78.94Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.74CX Basic pKa: 3.40CX LogP: 5.69CX LogD: 5.69Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: -1.78
References 1. Xie Z, Wu K, Wang Y, Pan Y, Chen B, Cheng D, Pan S, Guo T, Du X, Fang L, Wang X, Ye F.. (2020) Discovery of 4,6-pyrimidinediamine derivatives as novel dual EGFR/FGFR inhibitors aimed EGFR/FGFR1-positive NSCLC., 187 [PMID:31846829 ] [10.1016/j.ejmech.2019.111943 ]